Pharmaceutical Executive
Speed to market is crucial to the success of launching new products and therapies.
Don Steele
Advertisement
Articles by Don Steele
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Deny 340B Drug Pricing Due to Claims-Data Policy: Report
2
New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge
3
What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson from EVERSANA
4
Ascidian and Eli Lilly Enter $1.9 Billion Global Research Collaboration to Develop RNA Exon Editors
5